National Organization for Rare Disorders (NORD) logo. ... MPH, the newly appointed FDA CBER Director. More than 20 expert-led sessions exploring innovative study designs for small populations, ...

Former CBER director warns FDA staff cuts could upend drug review timelines as early as next year: BMO By Fraiser Kansteiner Apr 17, 2025 2:55pm U.S. FDA FDA review FDA approvals CBER ...

The Food and Drug Administration announced Tuesday it has picked a new head of its center charged with vaccine approvals and other biologics products: Dr. Vinay Prasad, a vocal critic of the ...

Virtus BBC ETF fell 9.74% to $17.15; SPDR XBI ETF dropped 6.63% to $77.17 on Tuesday. William Blair says Moderna faces increased scrutiny with mRNA vaccines under new CBER leadership. PPI and ...

WASHINGTON, May 23, 2025 /PRNewswire/ -- The National Organization for Rare Disorders (NORD®) will convene leading voices in science, industry, and regulation at its inaugural Rare Disease ...

FDA CBER Director Dr. Vinay Prasad to Keynote NORD's Inaugural Rare Disease Scientific Symposium, Convening Top Researchers, Industry Leaders, and Federal Regulators. News provided by.